IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target

• Auteurs principaux: Nicolaus Bruns VI (Auteur), Elizabeth H. Tressler (Auteur), Leandro F. Vendruscolo (Auteur), Lorenzo Leggio (Auteur), Mehdi Farokhnia (Auteur)
• Format: Livre
• Publié: Elsevier, 2024-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Addiction is a chronic relapsing disease with high morbidity and mortality. Treatments for addiction include pharmacological and psychosocial interventions; however, currently available medications are limited in number and efficacy. The glucagon-like-peptide-1 (GLP-1) system is emerging as a potent...